Applied Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/AApplied Therapeutics, Inc.APLTFeb 17

   Ownership stake disclosure by Vestal Point Capital, LP (amended)

   Vestal Point Capital, LP, filed by

2. ROUTINE15-12GApplied Therapeutics, Inc.APLTFeb 13

   Deregistration notice

3. ROUTINEEFFECTApplied Therapeutics, Inc.APLTFeb 9

   Registration declared effective

4. ROUTINEEFFECTApplied Therapeutics, Inc.APLTFeb 9

   Registration declared effective

5. ROUTINE4Applied Therapeutics, Inc.APLTFeb 4

   Stacy J. Kanter, insider filing for APLT

   Stacy J. Kanter, reporting

6. ROUTINE4Applied Therapeutics, Inc.APLTFeb 3

   6 insider filings

   Corwin Dale Hooks, insider filing for APLT

   Show all 6

   • 4Insider filing for APLTFeb 3
   • 4Insider filing for APLTFeb 3
   • 4Insider filing for APLTFeb 3
   • 4Insider filing for APLTFeb 3
   • 4Insider filing for APLTFeb 3
   • 4Insider filing for APLTFeb 3

   Corwin Dale Hooks, reporting

7. ROUTINEPOS AMApplied Therapeutics, Inc.APLTFeb 3

   POS AM filing

8. ROUTINEPOS AMApplied Therapeutics, Inc.APLTFeb 3

   POS AM filing

9. ROUTINES-8 POSApplied Therapeutics, Inc.APLTFeb 3

   S-8 POS filing

10. ROUTINES-8 POSApplied Therapeutics, Inc.APLTFeb 3

    S-8 POS filing

11. ROUTINES-8 POSApplied Therapeutics, Inc.APLTFeb 3

    S-8 POS filing

12. ROUTINES-8 POSApplied Therapeutics, Inc.APLTFeb 3

    S-8 POS filing

13. NOTABLE25-NSEApplied Therapeutics, Inc.APLTFeb 3

    Delisting notice

    Nasdaq Stock Market LLC, filed by

14. ROUTINE8-KApplied Therapeutics, Inc.APLTFeb 3

    Current report

15. ROUTINESC 14D9/AApplied Therapeutics, Inc.APLTFeb 3

    Tender offer response (amended)

16. ROUTINESC TO-T/AApplied Therapeutics, Inc.APLTFeb 3

    Tender offer (amended)

    AT2B, Inc., filed by

17. ROUTINESC 14D9/AApplied Therapeutics, Inc.APLTJan 30

    Tender offer response (amended)

18. ROUTINESC TO-T/AApplied Therapeutics, Inc.APLTJan 30

    Tender offer (amended)

    AT2B, Inc., filed by

19. ROUTINESC 14D9/AApplied Therapeutics, Inc.APLTJan 29

    Tender offer response (amended)

20. ROUTINESC TO-T/AApplied Therapeutics, Inc.APLTJan 29

    Tender offer (amended)

    AT2B, Inc., filed by

21. ROUTINESC 14D9/AApplied Therapeutics, Inc.APLTJan 28

    Tender offer response (amended)

22. ROUTINESC TO-T/AApplied Therapeutics, Inc.APLTJan 28

    Tender offer (amended)

    AT2B, Inc., filed by

23. ROUTINESC TO-T/AApplied Therapeutics, Inc.APLTJan 21

    Tender offer (amended)

    AT2B, Inc., filed by

24. ROUTINE4Applied Therapeutics, Inc.APLTJan 2

    Leslie D. Funtleyder, insider filing for APLT

    Leslie D. Funtleyder, reporting

25. ROUTINESCHEDULE 13G/AApplied Therapeutics, Inc.APLTDec 31, 2025

    Ownership stake disclosure by Propel Bio Management, LLC (amended)

    Propel Bio Management, LLC, filed by

26. NOTABLESC 14D9Applied Therapeutics, Inc.APLTDec 29, 2025

    Tender offer response

27. NOTABLESC TO-TApplied Therapeutics, Inc.APLTDec 29, 2025

    Tender offer

    AT2B, Inc., filed by

28. ROUTINE4Applied Therapeutics, Inc.APLTDec 18, 2025

    Stacy J. Kanter, insider filing for APLT

    Stacy J. Kanter, reporting

29. ROUTINE144Applied Therapeutics, Inc.APLTDec 16, 2025

    Stacy J. Kanter, planned sale of APLT shares

    Stacy J. Kanter, reporting

30. ROUTINESCHEDULE 13G/AApplied Therapeutics, Inc.APLTDec 15, 2025

    Ownership stake disclosure by ALEXANDRIA REAL ESTATE EQUITIES, INC. (amended)

    ALEXANDRIA REAL ESTATE EQUITIES, INC., filed by

31. ROUTINESC14D9CApplied Therapeutics, Inc.APLTDec 12, 2025

    SC14D9C filing

32. ROUTINE8-KApplied Therapeutics, Inc.APLTDec 12, 2025

    Current report

33. ROUTINE8-KApplied Therapeutics, Inc.APLTNov 20, 2025

    Applied Therapeutics, Inc. reported: Other Events.

    • Item 8.01 Other Events.
    • Item 9.01 Financial Statements and Exhibits.
34. ROUTINESCHEDULE 13G/AApplied Therapeutics, Inc.APLTNov 14, 2025

    Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)

    T. Rowe Price Investment Management, Inc., filed by

35. NOTABLE10-QApplied Therapeutics, Inc.APLTNov 13, 2025

    Quarterly report

36. ROUTINE8-KApplied Therapeutics, Inc.APLTNov 13, 2025

    Current report

Older filings on EDGAR